Impact of Genotype, Serum Bile Acids, and Surgical Biliary Diversion on Native Liver Survival in FIC1 Deficiency
Authors: van Wessel Daan B.E. , Thompson Richard J. , Gonzales Emmanuel , Jankowska Irena , Shneider Benjamin L. , Sokal Etienne , Grammatikopoulos Tassos , Kadaristiana Agustina , Jacquemin Emmanuel , Spraul Anne , Lipiński Patryk , Czubkowski Piotr , Rock Nathalie , Shagrani Mohammad , Broering Dieter , Algoufi Talal , Mazhar Nejat , Nicastro Emanuele , Kelly Deirdre , Nebbia Gabriella , Arnell Henrik , Fischler Björn , Hulscher Jan B.F. , Serranti Daniele , Arikan Cigdem , Debray Dominique , Lacaille Florence , Goncalves Cristina , Hierro Loreto , Muñoz Bartolo Gema , Mozer‐Glassberg Yael , Azaz Amer , Brecelj Jernej , Dezsőfi Antal , Luigi Calvo Pier , Krebs‐Schmitt Dorothee , Hartleif Steffen , van der Woerd Wendy L. , Wang Jian‐She , Li Li‐ting , Durmaz Özlem , Kerkar Nanda , Hørby Jørgensen Marianne , Fischer Ryan , Jimenez‐Rivera Carolina , Alam Seema , Cananzi Mara , Laverdure Noémie , Targa Ferreira Cristina , Ordonez Felipe , Wang Heng , Sency Valerie , Mo Kim Kyung , Chen Huey‐Ling , Carvalho Elisa , Fabre Alexandre , Quintero Bernabeu Jesus , Alonso Estella M. , Sokol Ronald J. , Suchy Frederick J. , Loomes Kathleen M. , McKiernan Patrick J. , Rosenthal Philip , Turmelle Yumirle , Rao Girish S. , Horslen Simon , Kamath Binita M. , Rogalidou Maria , Karnsakul Wikrom W. , Hansen Bettina , Verkade Henkjan J. ,   on behalf of Natural Course and Prognosis of PFIC and Effect of Biliary Diversion Consortium
Published: March 2021

Background and Aims

Mutations in ATPase phospholipid transporting 8B1 (ATP8B1) can lead to familial intrahepatic cholestasis type 1 (FIC1) deficiency, or progressive familial intrahepatic cholestasis type 1. The rarity of FIC1 deficiency has largely prevented a detailed analysis of its natural history, effects of predicted protein truncating mutations (PPTMs), and possible associations of serum bile acid (sBA) concentrations and surgical biliary diversion (SBD) with long‐term outcome. We aimed to provide insights by using the largest genetically defined cohort of patients with FIC1 deficiency to date.

Approach and Results

This multicenter, combined retrospective and prospective study included 130 patients with compound heterozygous or homozygous predicted pathogenic ATP8B1 variants. Patients were categorized according to the number of PPTMs (i.e., splice site, frameshift due to deletion or insertion, nonsense, duplication), FIC1‐A (n = 67; no PPTMs), FIC1‐B (n = 29; one PPTM), or FIC1‐C (n = 34; two PPTMs). Survival analysis showed an overall native liver survival (NLS) of 44% at age 18 years. NLS was comparable among FIC1‐A, FIC1‐B, and FIC1‐C (% NLS at age 10 years: 67%, 41%, and 59%, respectively; P = 0.12), despite FIC1‐C undergoing SBD less often (% SBD at age 10 years: 65%, 57%, and 45%, respectively; P = 0.03). sBAs at presentation were negatively associated with NLS (NLS at age 10 years, sBAs < 194 µmol/L: 49% vs. sBAs ≥ 194 µmol/L: 15%; P = 0.03). SBD decreased sBAs (230 [125‐282] to 74 [11‐177] μmol/L; P = 0.005). SBD (HR 0.55, 95% CI 0.28‐1.03, P = 0.06) and post‐SBD sBA concentrations < 65 μmol/L (P = 0.05) tended to be associated with improved NLS.

Conclusions

Less than half of patients with FIC1 deficiency reach adulthood with native liver. The number of PPTMs did not associate with the natural history or prognosis of FIC1 deficiency. sBA concentrations at initial presentation and after SBD provide limited prognostic information on long‐term NLS.